Skip to content
HowShorted

LIGAND PHARMACEUTICALS INC short interest in 2026

In 2026, LIGAND PHARMACEUTICALS INC's disclosed short interest ran from 6.44% of shares outstanding on 15 Jan 2026 to 13.20% on 15 Sep 2026, a change of +6.76 percentage points. The year's high was 13.20% on 15 Sep 2026 and its low 6.44% on 15 Jan 2026, averaging 8.77% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.12 days on 31 Aug 2026. Full history: LIGAND PHARMACEUTICALS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for LIGAND PHARMACEUTICALS INC in 2026

2026 in figures

Start of year
6.44% (15 Jan 2026)
End of year
13.20% (15 Sep 2026)
Change
+6.76 pp
High
13.20% (15 Sep 2026)
Low
6.44% (15 Jan 2026)
Average
8.77%
Highest days to cover
14.12 (31 Aug 2026)
SEC filings marked
6

Every report in 2026

LIGAND PHARMACEUTICALS INC short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20266.44%4.55
30 Jan 20266.52%6.49
13 Feb 20266.97%6.93
27 Feb 20266.91%9.02results (8-K), 10-K filed
13 Mar 20267.32%5.76
31 Mar 20267.50%6.45
15 Apr 20267.05%5.26
30 Apr 20267.30%7.97
15 May 20267.51%6.67results (8-K), 10-Q filed
29 May 20268.18%8.18
15 Jun 20268.43%8.33
30 Jun 202610.59%2.60
15 Jul 20269.57%4.99
31 Jul 202610.83%7.36
14 Aug 202612.28%8.76results (8-K), 10-Q filed
31 Aug 202612.44%14.12
15 Sep 202613.20%13.53

See also: LIGAND PHARMACEUTICALS INC's full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.